<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for CVM</title>
    <link />
    <description>Headlines for CEL-SCI Corp</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>CEL-SCI Presents Data Showing LEAPS Vaccine is Successful in Reducing Rheumatoid Arthritis Index Sco</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/06/cel-sci-presents-data-showing-leaps-vaccine-is-suc/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 06 May 2013 11:06:27 GMT</pubDate>
    </item>
    <item>
      <title>CEL-SCI To Present at the American Association of Immunologists 100th Annual Meeting on Saturday May</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/03/cel-sci-to-present-at-the-american-association-of-/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 03 May 2013 09:35:12 GMT</pubDate>
    </item>
    <item>
      <title>Biotech Stock Mailbag: ASCO, Sarepta, Cel-Sci and Hate Mail!</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11906065/1/biotech-stock-mailbag-asco-sarepta-cel-sci-and-hate-mail.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Fri, 26 Apr 2013 08:15:00 GMT</pubDate>
    </item>
    <item>
      <title>CEL-SCI Issues Update on Phase 3 Trial, Says Enough Patients Enrolled to Date</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/04/3519690/cel-sci-issues-update-on-phase-3-trial-says-enough-patients-enrolled-to-date.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Tue, 23 Apr 2013 08:10:33 GMT</pubDate>
    </item>
    <item>
      <title>Three Biotech Stocks With Low Price But Great Potential</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1343641-three-biotech-stocks-with-low-price-but-great-potential.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 16 Apr 2013 06:17:19 GMT</pubDate>
    </item>
    <item>
      <title>BioCryst Won't Profit From Bird Flu Outbreak in China</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11889822/1/biocryst-wont-profit-from-bird-flu-outbreak-in-china.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Mon, 08 Apr 2013 15:11:00 GMT</pubDate>
    </item>
    <item>
      <title>CEL-SCI Corporation Announces That NIAID Collaborators Have Submitted Bird Flu Study for Publication</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/04/08/cel-sci-corporation-announces-that-niaid-collabora/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 08 Apr 2013 13:20:22 GMT</pubDate>
    </item>
    <item>
      <title>UPDATE: CEL-SCI Announces NIAID Collaborators Have Submitted Bird Flu Study for Publication to Scien</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/04/3479301/update-cel-sci-announces-niaid-collaborators-have-submitted-bird-flu-study-for-pu.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Mon, 08 Apr 2013 13:03:35 GMT</pubDate>
    </item>
    <item>
      <title>CEL-SCI Corporation Releases New Video on Its Website</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/04/02/cel-sci-corporation-releases-new-video-on-its-webs/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 02 Apr 2013 08:20:34 GMT</pubDate>
    </item>
    <item>
      <title>CEL-SCI Announces Initiation of New Sites for Multikine Phase III Clinical Study for Head and Neck C</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/02/25/cel-sci-announces-initiation-of-new-sites-for-mult/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 25 Feb 2013 14:51:37 GMT</pubDate>
    </item>
    <item>
      <title>UPDATE: Taglich Brothers Initiates CEL-SCI Corporation at Speculative Buy on Multikine Outlook</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/02/3348223/update-taglich-brothers-initiates-cel-sci-corporation-at.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Wed, 20 Feb 2013 07:28:12 GMT</pubDate>
    </item>
    <item>
      <title>CEL-SCI Corporation Reports First Quarter 2013 Financial Results</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/02/08/cel-sci-corporation-reports-first-quarter-2013-fin/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 08 Feb 2013 16:32:59 GMT</pubDate>
    </item>
    <item>
      <title>CEL-SCI to Present at 15th Annual BIO CEO &amp; Investor Conference</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/02/07/cel-sci-to-present-at-15th-annual-bio-ceo-investor/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 07 Feb 2013 08:28:16 GMT</pubDate>
    </item>
    <item>
      <title>CEL-SCI and Northeast Ohio Medical University Develop Novel Cancer Vaccine That Prevents and Treats</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/01/31/cel-sci-and-northeast-ohio-medical-university-deve/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 31 Jan 2013 09:26:10 GMT</pubDate>
    </item>
    <item>
      <title>CEL-SCI Corporation Announces Fiscal 2012 Financial Results</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2012/12/14/cel-sci-corporation-announces-fiscal-2012-financia/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 14 Dec 2012 16:35:13 GMT</pubDate>
    </item>
    <item>
      <title>Cel-Sci: Immunotherapy Opens New Door To Investors</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1050721-cel-sci-immunotherapy-opens-new-door-to-investors.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 06 Dec 2012 23:11:04 GMT</pubDate>
    </item>
    <item>
      <title>4 Undervalued And Technically Oversold Healthcare Penny Stocks Poised To Bounce</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1020501-4-undervalued-and-technically-oversold-healthcare-penny-stocks-poised-to-bounce.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 20 Nov 2012 09:58:08 GMT</pubDate>
    </item>
    <item>
      <title>Cel-Sci's Successful Safety Review Not Yet Factored Into Valuation</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/972191-cel-sci-s-successful-safety-review-not-yet-factored-into-valuation.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 02 Nov 2012 05:20:24 GMT</pubDate>
    </item>
    <item>
      <title>Risk Vs. Reward Never Gets Old</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/940811-risk-vs-reward-never-gets-old.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 23 Oct 2012 07:36:12 GMT</pubDate>
    </item>
    <item>
      <title>CEL-SCI Corporation Announces Results of Interim Review of Data from Its Ongoing Phase III Head and</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2012/10/22/cel-sci-corporation-announces-results-of-interim-r/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 22 Oct 2012 10:21:23 GMT</pubDate>
    </item>
  </channel>
</rss>
